Heart attack

A potential new drug to improve the long-term outcomes for heart attack patients will be trialled in the UK under a new agreement.  The Phase IIb LIBERATE study will test the tolerance and the efficacy of glenzocimab 1000mg to reduce heart damage following a myocardial infarction (MI). According to the partnership between the University of […]

A drug candidate for heart attacks which contains venom from a deadly spider has moved closer to clinical trials due to investment of $23 million.  A research team at the University of Queensland have developed a potential therapy for heart attacks and stroke which uses a molecule found in the venom of the K’gari (Fraser […]